Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>		A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.2176/nmc.ra.2014-0264

http://scihub22266oqcxt.onion/10.2176/nmc.ra.2014-0264
suck pdf from google scholar
C4533405!4533405 !25746305
unlimited free pdf from europmc25746305     free
PDF from PMC    free
html from PMC    free

Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=25746305 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215

suck abstract from ncbi


Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\25746305 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117
pmid25746305       Neurol+Med+Chir+(Tokyo) 2015 ; 55 (2 ): 113-23
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Regenerative medicine for Parkinson s disease #MMPMID25746305
  • Yasuhara T ; Kameda M ; Agari T ; Date I
  • Neurol Med Chir (Tokyo) 2015[]; 55 (2 ): 113-23 PMID25746305 show ga
  • Regenerative medicine for Parkinson's disease (PD) is expected to develop dramatically with the advancement of biotechnology as represented by induced pluripotent stem cells. Existing therapeutic strategy for PD consists of medication using L-DOPA, surgery such as deep brain stimulation and rehabilitation. Current treatment cannot stop the progression of the disease, although there is definite therapeutic effect. True neurorestoration is strongly desired by regenerative medicine. This review article describes the historical development of regenerative medicine for PD, with a focus on fetal nigral cell transplantation and glial cell line-derived neurotrophic factor infusion. Subsequently, the current status of regenerative medicine for PD in terms of cell therapy and gene therapy are reviewed. In the end, the future direction to realize regenerative medicine for PD is discussed.
  • |Animals [MESH]
  • |Antiparkinson Agents/therapeutic use [MESH]
  • |Cell- and Tissue-Based Therapy/methods [MESH]
  • |Clinical Trials as Topic [MESH]
  • |Combined Modality Therapy [MESH]
  • |Dopaminergic Neurons/drug effects/physiology [MESH]
  • |Drug Discovery [MESH]
  • |Fetal Stem Cells/transplantation [MESH]
  • |Genetic Therapy/methods [MESH]
  • |Glial Cell Line-Derived Neurotrophic Factors/therapeutic use [MESH]
  • |Humans [MESH]
  • |Levodopa/therapeutic use [MESH]
  • |Parkinson Disease/physiopathology/*therapy [MESH]
  • |Pluripotent Stem Cells/transplantation [MESH]
  • |Regenerative Medicine/*methods [MESH]


  • DeepDyve
  • Pubget Overpricing

    • suck abstract from ncbi

    Linkout box